{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:17:31Z","timestamp":1772914651210,"version":"3.50.1"},"reference-count":144,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR131021"],"award-info":[{"award-number":["NIHR131021"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title>\n<jats:p>Pharmacological prophylaxis to prevent venous thromboembolism is currently recommended for women assessed as being at high risk of venous thromboembolism during pregnancy or in the 6 weeks after delivery (the puerperium). The decision to provide thromboprophylaxis involves weighing the benefits, harms and costs, which vary according to the individual\u2019s venous thromboembolism risk. It is unclear whether the United Kingdom\u2019s current risk stratification approach could be improved by further research.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-2\"><jats:title>Objectives<\/jats:title>\n<jats:p>To quantify the current decision uncertainty associated with selecting women who are pregnant or in the puerperium for thromboprophylaxis and to estimate the value of one or more potential future studies that would reduce that uncertainty, while being feasible and acceptable to patients and clinicians.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-3\"><jats:title>Methods<\/jats:title>\n<jats:p>A decision-analytic model was developed which was informed by a systematic review of risk assessment models to predict venous thromboembolism in women who are pregnant or in the puerperium. Expected value of perfect information analysis was used to determine which factors are associated with high decision uncertainty and should be the target of future research. To find out whether future studies would be acceptable and feasible, we held workshops with women who have experienced a blood clot or have been offered blood-thinning drugs and surveyed healthcare professionals. Expected value of sample information analysis was used to estimate the value of potential future research studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-4\"><jats:title>Results<\/jats:title>\n<jats:p>The systematic review included 17 studies, comprising 19 unique externally validated risk assessment models and 1 internally validated model. Estimates of sensitivity and specificity were highly variable ranging from 0% to 100% and 5% to 100%, respectively. Most studies had unclear or high risk of bias and applicability concerns.<\/jats:p>\n<jats:p>The decision analysis found that there is substantial decision uncertainty regarding the use of risk assessment models to select high-risk women for antepartum prophylaxis and obese postpartum women for postpartum prophylaxis. The main source of decision uncertainty was uncertainty around the effectiveness of thromboprophylaxis for preventing venous thromboembolism in women who are pregnant or in the puerperium. We found that a randomised controlled trial of thromboprophylaxis in obese postpartum women is likely to have substantial value and is more likely to be acceptable and feasible than a trial recruiting women who have had a previous venous thromboembolism. In unselected postpartum women and women following caesarean section, the poor performance of risk assessment models meant that offering prophylaxis based on these models had less favourable cost effectiveness with lower decision uncertainty.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-5\"><jats:title>Limitations<\/jats:title>\n<jats:p>The performance of the risk assessment model for obese postpartum women has not been externally validated.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-6\"><jats:title>Conclusions<\/jats:title>\n<jats:p>Future research should focus on estimating the efficacy of pharmacological thromboprophylaxis in pregnancy and the puerperium, and clinical trials would be more acceptable in women who have not had a previous venous thromboembolism.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-7\"><jats:title>Study registration<\/jats:title>\n<jats:p>This study is registered as PROSPERO CRD42020221094.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-8\"><jats:title>Funding<\/jats:title>\n<jats:p>This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR131021) and is published in full in <jats:italic>Health Technology Assessment<\/jats:italic>; Vol. 28, No. 9. See the NIHR Funding and Awards website for further award information.<\/jats:p>\n<\/jats:sec>","DOI":"10.3310\/dfwt3873","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:08:23Z","timestamp":1710313703000},"page":"1-176","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-4287","authenticated-orcid":true,"given":"Sarah","family":"Davis","sequence":"first","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-5260","authenticated-orcid":true,"given":"Abdullah","family":"Pandor","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2321-0302","authenticated-orcid":true,"given":"Fiona C","family":"Sampson","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-9842","authenticated-orcid":true,"given":"Jean","family":"Hamilton","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-1196","authenticated-orcid":true,"given":"Catherine","family":"Nelson-Piercy","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Academic Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-0774","authenticated-orcid":true,"given":"Beverley J","family":"Hunt","sequence":"additional","affiliation":[{"name":"Haematology and Pathology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5816-2609","authenticated-orcid":true,"given":"Jahnavi","family":"Daru","sequence":"additional","affiliation":[{"name":"Institute of Population Health Sciences, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-8444","authenticated-orcid":true,"given":"Steve","family":"Goodacre","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-868X","authenticated-orcid":true,"given":"Rosie","family":"Carser","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement, Thrombosis UK, Llanwrda, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8388-9444","authenticated-orcid":true,"given":"Gill","family":"Rooney","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-9946","authenticated-orcid":true,"given":"Mark","family":"Clowes","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2024,3]]},"reference":[{"key":"key2024031312255700_ref1-bib1","volume-title":"Saving Lives, Improving Mother\u2019s Care: Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2017\u201319","author":"Knight","year":"2021"},{"key":"key2024031312255700_ref2-bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"key2024031312255700_ref3-bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref4-bib4","first-page":"595","article-title":"Thrombotic risk during pregnancy: a population study","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref5-bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/14767058.2014.913130","article-title":"Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis","volume":"28","author":"Meng","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key2024031312255700_ref8-bib8","article-title":"Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period","volume":"3","author":"Middleton","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"key2024031312255700_ref9-bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12872-019-1183-3","article-title":"Critical appraisal of international guidelines for the prevention and treatment of pregnancy-associated venous thromboembolism: a systematic review","volume":"19","author":"Zheng","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"key2024031312255700_ref10-bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/1471-0528.15150","article-title":"Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens","volume":"125","author":"Kotaska","year":"2018","journal-title":"BJOG"},{"key":"key2024031312255700_ref11-bib11","doi-asserted-by":"crossref","first-page":"i6253","DOI":"10.1136\/bmj.i6253","article-title":"Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study","volume":"355","author":"Sultan","year":"2016","journal-title":"BMJ"},{"key":"key2024031312255700_ref12-bib12","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/1471-0528.13706","article-title":"A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines","volume":"123","author":"Palmerola","year":"2016","journal-title":"BJOG"},{"key":"key2024031312255700_ref13-bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjh.15417","article-title":"Venous thromboembolic risk assessment in pregnancy: comparison of the All-Wales maternity risk assessment tool with guidance from the Royal College of Obstetrics and Gynaecology","volume":"185","author":"Shacaluga","year":"2019","journal-title":"Br J Haematol"},{"key":"key2024031312255700_ref14-bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1258\/om.2010.100042","article-title":"Thrombosis and embolism in pregnancy and the puerperium, reducing the risk: what proportion of patients reach the threshold for thromboprophylaxis?","volume":"4","author":"Revell","year":"2011","journal-title":"Obstet Med"},{"key":"key2024031312255700_ref15-bib15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/jth.14568","article-title":"Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population","volume":"17","author":"O\u2019Shaughnessy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref16-bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8310","article-title":"A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme","volume":"8","author":"Claxton","year":"2004","journal-title":"Health Technol Assess"},{"key":"key2024031312255700_ref17-bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0272989X04263162","article-title":"Expected value of sample information calculations in medical decision modeling","volume":"24","author":"Ades","year":"2004","journal-title":"Med Decis Making"},{"key":"key2024031312255700_ref18-bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1160\/TH14-06-0485","article-title":"PROSPER Investigators Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial","volume":"113","author":"Rodger","year":"2015","journal-title":"Thromb Haemost"},{"key":"key2024031312255700_ref19-bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2016.04.004","article-title":"Low molecular weight heparin to prevent postpartum venous thromboembolism: a pilot study to assess the feasibility of a randomized, open-label trial","volume":"142","author":"Rodger","year":"2016","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref20-bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"key2024031312255700_ref21-bib21","volume-title":"McMaster University \u2013 HiRU\u2019s Approach to Search Filter Development","author":"Wilczynski"},{"key":"key2024031312255700_ref22-bib22","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"key2024031312255700_ref23-bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"key2024031312255700_ref25-bib25","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2","author":"McKenzie","year":"2021"},{"key":"key2024031312255700_ref26-bib26","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"key2024031312255700_ref27-bib27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1160\/TH07-05-0329","article-title":"Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women","volume":"98","author":"Bauersachs","year":"2007","journal-title":"Thromb Haemost"},{"key":"key2024031312255700_ref28-bib28","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1097\/01.AOG.0000558997.74246.16","article-title":"Development of a venous thromboembolism prevention tool in the postpartum period","volume":"133","author":"Binstock","year":"2019","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref29-bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.thromres.2011.06.028","article-title":"Thromboprophylaxis following cesarean delivery: one site prospective pilot study to evaluate the application of a risk score model","volume":"129","author":"Cavazza","year":"2012","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref30-bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12754","article-title":"Use of a personalized iterative score to evaluate risk of venous thromboembolism during pregnancy and puerperium","volume":"144","author":"Chau","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"key2024031312255700_ref31-bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.thromres.2007.12.020","article-title":"Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women","volume":"122","author":"Chauleur","year":"2008","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref32-bib32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jth.13660","article-title":"Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study","volume":"15","author":"Dargaud","year":"2017","journal-title":"J Thromb Haemos JTH"},{"key":"key2024031312255700_ref33-bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijgo.2005.05.003","article-title":"Management of pregnant women with increased risk of venous thrombosis","volume":"90","author":"Dargaud","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"key2024031312255700_ref34-bib34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.15166","article-title":"Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis","volume":"19","author":"Gassmann","year":"2020","journal-title":"J Thromb Haemos"},{"key":"key2024031312255700_ref35-bib35","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.6061\/clinics\/2018\/e368","article-title":"Risk assessment of venous thromboembolism and thromboprophylaxis in pregnant women hospitalized with cancer: preliminary results from a risk score","volume":"73","author":"Hase","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"key2024031312255700_ref36-bib36","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/VHRM.S2831","article-title":"Postpartum thromboembolism: severe events might be preventable using a new risk score model","volume":"4","author":"Lindqvist","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"key2024031312255700_ref37-bib37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tjog.2019.05.016","article-title":"A local risk score model for venous thromboembolism prophylaxis for caesarean section in Chinese women and comparison with international guidelines","volume":"58","author":"Lok","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"key2024031312255700_ref38-bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11739-014-1111-6","article-title":"The \u2018Pregnancy Health-care Program\u2019 for the prevention of venous thromboembolism in pregnancy","volume":"10","author":"Testa","year":"2015","journal-title":"Intern Emerg Med"},{"key":"key2024031312255700_ref39-bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/1933719118813197","article-title":"Performance of risk assessment models for peripartum thromboprophylaxis","volume":"26","author":"Tran","year":"2019","journal-title":"Reprod Sci"},{"key":"key2024031312255700_ref40-bib40","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1067\/mob.2000.105441","article-title":"Risk factor scoring for predicting venous thromboembolism in obstetric patients","volume":"182","author":"Weiss","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref41-bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2020.03.025","article-title":"Developing a model for predicting venous thromboembolism in obese pregnant women in a national study","volume":"191","author":"Ellis-Kahana","year":"2020","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref42-bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"key2024031312255700_ref43-bib43","doi-asserted-by":"crossref","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLOS Med"},{"key":"key2024031312255700_ref45-bib45","volume-title":"Unit Costs of Health and Social Care","author":"Curtis","year":"2020"},{"key":"key2024031312255700_ref46-bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23630","article-title":"Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation","volume":"23","author":"Pandor","year":"2019","journal-title":"Health Technol Assess"},{"key":"key2024031312255700_ref47-bib47","article-title":"An evidence synthesis and economic evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM project","author":"Horner","year":"2021","journal-title":"Health Technol Assess"},{"key":"key2024031312255700_ref48-bib48","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jth.14576","article-title":"Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: a systematic review and a proposal from the ISTH SSC","volume":"17","author":"Tardy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref49-bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"key2024031312255700_ref50-bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.thromres.2016.05.016","article-title":"Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density","volume":"143","author":"Galambosi","year":"2016","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref51-bib51","volume-title":"Health Survey for England 2019 Overweight and Obesity in Adults and Children","author":"Moody","year":"2020"},{"key":"key2024031312255700_ref52-bib52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"De Stefano","year":"2006","journal-title":"Br J Haematol"},{"key":"key2024031312255700_ref53-bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref54-bib54","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"key2024031312255700_ref55-bib55","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1182\/blood-2014-05-572834","article-title":"Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England","volume":"124","author":"Sultan","year":"2014","journal-title":"Blood"},{"key":"key2024031312255700_ref56-bib56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.chest.2016.05.021","article-title":"Risks of venous thromboembolism after cesarean sections: a meta-analysis","volume":"150","author":"Blondon","year":"2016","journal-title":"Chest"},{"key":"key2024031312255700_ref57-bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.thromres.2008.06.004","article-title":"The incidence of deep vein thrombosis in women undergoing cesarean delivery","volume":"123","author":"Sia","year":"2009","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref58-bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1471-0528.1995.tb09104.x","article-title":"Duplex ultrasound screening for deep venous thrombosis in the puerperium","volume":"102","author":"Macklon","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"key2024031312255700_ref59-bib59","first-page":"418","article-title":"Low incidence of asymptomatic deep venous thrombosis following caesarean section: a colour Doppler study","volume":"57","author":"Kalro","year":"1999","journal-title":"Health Bull (Edinb)"},{"key":"key2024031312255700_ref60-bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.thromres.2004.03.008","article-title":"Deep vein thrombosis after elective cesarean section","volume":"113","author":"Jacobsen","year":"2004","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref61-bib61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tjog.2014.09.008","article-title":"Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: a multi-center study in Japan","volume":"54","author":"Goto","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"key2024031312255700_ref62-bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.0001-6349.2005.00591.x","article-title":"Duplex ultrasound screening for deep vein thrombosis in Chinese after cesarean section","volume":"84","author":"Chan","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024031312255700_ref63-bib63","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1055\/s-0040-1714211","article-title":"Clinical characteristics and outcomes of women presenting with venous thromboembolism during pregnancy and postpartum period: findings from the RIETE registry","volume":"120","author":"Elgendy","year":"2020","journal-title":"Thromb Haemost"},{"key":"key2024031312255700_ref64-bib64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"FRUIT Investigators Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"van Hoorn","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2024031312255700_ref65-bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"FRUIT Investigators Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"de Vries","year":"2012","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref66-bib66","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"key":"key2024031312255700_ref67-bib67","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref68-bib68","first-page":"835","article-title":"A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study","volume":"108","author":"Burrows","year":"2001","journal-title":"BJOG"},{"key":"key2024031312255700_ref69-bib69","first-page":"s197","article-title":"Thromboembolism prophylaxis after cesarean section (PRO-CS) trial","volume":"130","author":"Algahtani","year":"2015","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref70-bib70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejogrb.2011.08.005","article-title":"Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile","volume":"159","author":"Nelson-Piercy","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2024031312255700_ref71-bib71","doi-asserted-by":"crossref","first-page":"652796","DOI":"10.1155\/2011\/652796","article-title":"The use of a scoring system to guide thromboprophylaxis in a high-risk pregnant population","volume":"2011","author":"Schoenbeck","year":"2011","journal-title":"Thrombosis"},{"key":"key2024031312255700_ref72-bib72","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/jth.14452","article-title":"Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism","volume":"17","author":"Cox","year":"2019","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref73-bib73","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref74-bib74","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0412.2011.01098.x","article-title":"Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism","volume":"90","author":"Lindqvist","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2024031312255700_ref76-bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/jpm-2013-0160","article-title":"Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: should maternal age have a role in decision making?","volume":"42","author":"Gizzo","year":"2014","journal-title":"J Perinat Med"},{"key":"key2024031312255700_ref77-bib77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/AOG.0b013e3182029180","article-title":"Rate of wound complications with enoxaparin use among women at high risk for postpartum thrombosis","volume":"117","author":"Ferres","year":"2011","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref78-bib78","volume-title":"Saving Lives, Improving Mother\u2019s Care: Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2016\u201318","author":"Knight","year":"2020"},{"key":"key2024031312255700_ref79-bib79","doi-asserted-by":"crossref","first-page":"e004601","DOI":"10.1161\/JAHA.116.004601","article-title":"Incidence of first stroke in pregnant and nonpregnant women of childbearing age: a population-based cohort study from England","volume":"6","author":"Ban","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key2024031312255700_ref80-bib80","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1055\/s-0040-1722611","article-title":"Pregnancy-associated venous thromboembolism: insights from GARFIELD-VTE","volume":"5","author":"Jerjes-Sanchez","year":"2021","journal-title":"TH Open"},{"key":"key2024031312255700_ref81-bib81","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1538-7836.2010.03852.x","article-title":"Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry","volume":"8","author":"Nieto","year":"2010","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref82-bib82","doi-asserted-by":"crossref","first-page":"1601792","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","volume":"49","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respir J"},{"key":"key2024031312255700_ref83-bib83","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N Engl J Med"},{"key":"key2024031312255700_ref84-bib84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijgo.2015.06.054","article-title":"A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women","volume":"132","author":"Kourlaba","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"key2024031312255700_ref85-bib85","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1538-7836.2012.04690.x","article-title":"Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study","volume":"10","author":"Wik","year":"2012","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref86-bib86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1538-7836.2005.01333.x","article-title":"Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome","volume":"3","author":"van Dongen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"key2024031312255700_ref87-bib87","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/jnnp.2004.055145","article-title":"Long term survival after primary intracerebral haemorrhage: a retrospective population based study","volume":"76","author":"Fogelholm","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2024031312255700_ref88-bib88","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1701-2163(16)34240-2","article-title":"Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada","volume":"31","author":"Liu","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"key2024031312255700_ref89-bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22470","article-title":"Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modelling","volume":"22","author":"Goodacre","year":"2018","journal-title":"Health Technol Assess"},{"key":"key2024031312255700_ref90-bib90","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","article-title":"Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an International Prospective Registry","volume":"133","author":"Delcroix","year":"2016","journal-title":"Circulation"},{"key":"key2024031312255700_ref93-bib93","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1302\/0301-620X.95B5.30555","article-title":"The cost of outpatient venous thromboembolism prophylaxis following lower limb injuries","volume":"95-B","author":"Menakaya","year":"2013","journal-title":"Bone Joint J"},{"key":"key2024031312255700_ref95-bib95","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.thromres.2021.01.024","article-title":"An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism","volume":"200","author":"McFarlane","year":"2021","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref96-bib96","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/emermed-2019-209213","article-title":"Accuracy of PE rule-out strategies in pregnancy: secondary analysis of the DiPEP study prospective cohort","volume":"37","author":"Goodacre","year":"2020","journal-title":"Emerg Med J"},{"key":"key2024031312255700_ref97-bib97","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2007.01622.x","article-title":"Antenatal pulmonary embolism: risk factors, management and outcomes","volume":"115","author":"Knight","year":"2008","journal-title":"BJOG"},{"key":"key2024031312255700_ref98-bib98","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1747-4949.2012.00812.x","article-title":"Population-based study of acute- and long-term care costs after stroke in patients with AF","volume":"8","author":"Luengo-Fernandez","year":"2013","journal-title":"Int J Stroke"},{"key":"key2024031312255700_ref99-bib99","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.amjmed.2004.12.009","article-title":"Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism","volume":"118","author":"Johnston","year":"2005","journal-title":"Am J Med"},{"key":"key2024031312255700_ref100-bib100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s41669-018-0108-x","article-title":"Uterotonic drugs for the prevention of postpartum haemorrhage: a cost-effectiveness analysis","volume":"3","author":"Pickering","year":"2019","journal-title":"PharmacoEconomics Open"},{"key":"key2024031312255700_ref101-bib101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejogrb.2021.11.432","article-title":"A study of the healthcare resource use for the management of postpartum haemorrhage in France, Italy, the Netherlands, and the UK","volume":"268","author":"Richardson","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2024031312255700_ref102-bib102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1524-4733.2003.00204.x","article-title":"Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States","volume":"6","author":"Caprini","year":"2003","journal-title":"Value Health"},{"key":"key2024031312255700_ref103-bib103","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/bloodadvances.2019000462","article-title":"Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines","volume":"4","author":"Etxeandia-Ikobaltzeta","year":"2020","journal-title":"Blood Adv"},{"key":"key2024031312255700_ref104-bib104","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s11136-019-02175-z","article-title":"Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries","volume":"28","author":"Chuang","year":"2019","journal-title":"Qual Life Res"},{"key":"key2024031312255700_ref105-bib105","doi-asserted-by":"crossref","first-page":"1076029619883946","DOI":"10.1177\/1076029619883946","article-title":"Deep vein thrombosis in Europe-Health-Related Quality of Life and Mortality","volume":"25","author":"Monreal","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"key2024031312255700_ref106-bib106","doi-asserted-by":"crossref","first-page":"e002984","DOI":"10.1136\/bmjopen-2013-002984","article-title":"Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study","volume":"3","author":"Enden","year":"2013","journal-title":"BMJ Open"},{"key":"key2024031312255700_ref107-bib107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jamia.1997.0040049","article-title":"Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis","volume":"4","author":"Lenert","year":"1997","journal-title":"J Am Med Inform Assoc"},{"key":"key2024031312255700_ref108-bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jvsv.2012.07.003","article-title":"Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS Registry","volume":"1","author":"Hach-Wunderle","year":"2013","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"key2024031312255700_ref109-bib109","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1183\/09031936.00069708","article-title":"The responsiveness and validity of the CAMPHOR Utility Index","volume":"32","author":"Meads","year":"2008","journal-title":"Eur Respir J"},{"key":"key2024031312255700_ref110-bib110","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.0b013e3182a9f45f","article-title":"Quality of life after TIA and stroke: ten-year results of the Oxford vascular study","volume":"81","author":"Luengo-Fernandez","year":"2013","journal-title":"Neurology"},{"key":"key2024031312255700_ref111-bib111","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-9343(01)00793-8","article-title":"Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis","volume":"111","author":"Marchetti","year":"2001","journal-title":"Am J Med"},{"key":"key2024031312255700_ref112-bib112","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jval.2010.10.029","article-title":"Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available","volume":"14","author":"Ara","year":"2011","journal-title":"Value Health"},{"key":"key2024031312255700_ref113-bib113","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06826.x","article-title":"The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey","volume":"139","author":"Voke","year":"2007","journal-title":"Br J Haematol"},{"key":"key2024031312255700_ref114-bib114","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1182\/blood-2012-11-469551","article-title":"Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom","volume":"121","author":"Sultan","year":"2013","journal-title":"Blood"},{"key":"key2024031312255700_ref115-bib115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0272989X13505910","article-title":"Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach","volume":"34","author":"Strong","year":"2014","journal-title":"Med Decis Making"},{"key":"key2024031312255700_ref116-bib116","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jval.2020.02.010","article-title":"Computing the expected value of sample information efficiently: practical guidance and recommendations for four model-based methods","volume":"23","author":"Kunst","year":"2020","journal-title":"Value Health"},{"key":"key2024031312255700_ref118-bib118","doi-asserted-by":"crossref","first-page":"e026220","DOI":"10.1136\/bmjopen-2018-026220","article-title":"Is maternal weight gain between pregnancies associated with risk of large-for-gestational age birth? Analysis of a UK population-based cohort","volume":"9","author":"Ziauddeen","year":"2019","journal-title":"BMJ Open"},{"key":"key2024031312255700_ref119-bib119","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.wombi.2017.12.009","article-title":"Facilitators and barriers to pregnant women\u2019s participation in research: a systematic review","volume":"31","author":"van der Zande","year":"2018","journal-title":"Women Birth"},{"key":"key2024031312255700_ref120-bib120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2003-38318","article-title":"Participation of pregnant women in clinical trials: will they participate and why?","volume":"20","author":"Rodger","year":"2003","journal-title":"Am J Perinatol"},{"key":"key2024031312255700_ref121-bib121","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","article-title":"One size fits all? What counts as quality practice in (reflexive) thematic analysis?","volume":"18","author":"Braun","year":"2021","journal-title":"Qual Res Psychol"},{"key":"key2024031312255700_ref122-bib122","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0272989X15575286","article-title":"Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast, nonparametric regression-based method","volume":"35","author":"Strong","year":"2015","journal-title":"Med Decis Making"},{"key":"key2024031312255700_ref123-bib123","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40537-021-00501-2","article-title":"Design matters in patient-level prediction: evaluation of a cohort vs. case-control design when developing predictive models in observational healthcare datasets","volume":"8","author":"Reps","year":"2021","journal-title":"J Big Data"},{"key":"key2024031312255700_ref124-bib124","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Updated February 2021)","author":"Higgins","year":"2021"},{"key":"key2024031312255700_ref125-bib125","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1016\/j.midw.2011.08.006","article-title":"Deciding to join a perinatal randomised controlled trial: experiences and views of pregnant women enroled in the Magpie Trial","volume":"28","author":"Smyth","year":"2012","journal-title":"Midwifery"},{"key":"key2024031312255700_ref126-bib126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12884-019-2209-7","article-title":"A qualitative study on stakeholders\u2019 views on the participation of pregnant women in the APOSTEL VI study: a low-risk obstetrical RCT","volume":"19","author":"van der Zande","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"key2024031312255700_ref127-bib127","doi-asserted-by":"crossref","first-page":"e0234783","DOI":"10.1371\/journal.pone.0234783","article-title":"Recruiters\u2019 perspectives of recruiting women during pregnancy and childbirth to clinical trials: a qualitative evidence synthesis","volume":"15","author":"Hanrahan","year":"2020","journal-title":"PLOS ONE"},{"key":"key2024031312255700_ref128-bib128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2393-8-36","article-title":"A thematic analysis of factors influencing recruitment to maternal and perinatal trials","volume":"8","author":"Tooher","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"key":"key2024031312255700_ref129-bib129","first-page":"1","article-title":"Recruiting ethnically diverse participants into qualitative health research: lessons learned","volume":"18","author":"Renert","year":"2013","journal-title":"Qual Rep"},{"key":"key2024031312255700_ref130-bib130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/pubmed\/fdq100","article-title":"Promoting recruitment of minority ethnic groups into research: qualitative study exploring the views of South Asian people with asthma","volume":"33","author":"Rooney","year":"2011","journal-title":"J Public Health (Oxf)"},{"key":"key2024031312255700_ref131-bib131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jclinepi.2022.01.015","article-title":"Theory-guided interviews identified _behavioral barriers and enablers to healthcare professionals recruiting participants to maternity trials","volume":"145","author":"Hanrahan","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"key2024031312255700_ref132-bib132","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/AOG.0000000000002707","article-title":"ACOG Practice Bulletin No. 196 Summary: thromboembolism in pregnancy","volume":"132","author":"James","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref133-bib133","doi-asserted-by":"crossref","first-page":"157483","DOI":"10.1155\/2011\/157483","article-title":"Obstetric thromboprophylaxis: the Swedish guidelines","volume":"2011","author":"Lindqvist","year":"2011","journal-title":"Adv Hematol"},{"key":"key2024031312255700_ref134-bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10110","article-title":"Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study","volume":"10","author":"Wu","year":"2006","journal-title":"Health Technol Assess"},{"key":"key2024031312255700_ref135-bib135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haematol"},{"key":"key2024031312255700_ref136-bib136","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOH.0b013e32825f5318","article-title":"Is screening for thrombophilia cost-effective?","volume":"14","author":"Wu","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"key2024031312255700_ref137-bib137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2018.03.028","article-title":"Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: a systematic review and cost analysis","volume":"224","author":"Wormer","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2024031312255700_ref138-bib138","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/j.ajog.2011.10.854","article-title":"The cost-effectiveness of thromboprophylaxis with low-molecular weight heparin or unfractionated heparin after cesarean delivery","volume":"206","author":"Westhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref139-bib139","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1097\/01.AOG.0000664664.88371.1c","article-title":"Pregnancy-adapted years algorithm for diagnosing suspected pulmonary embolism: a cost-effectiveness analysis","volume":"135","author":"Sievert","year":"2020","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref140-bib140","doi-asserted-by":"crossref","first-page":"S543","DOI":"10.1016\/j.ajog.2018.11.855","article-title":"832: Universal screening of inherited thrombophilias to reduce venous thromboembolism risk in pregnancy: a decision analysis","volume":"220","author":"Sabol","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref141-bib141","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood.V122.21.426.426","article-title":"Cost-effectiveness of thromboprophylaxis in pregnant women with sickle cell disease","volume":"122","author":"Rizvi","year":"2013","journal-title":"Blood"},{"key":"key2024031312255700_ref142-bib142","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.AOG.0000178792.51401.3a","article-title":"Thromboprophylaxis after cesarean delivery: a decision analysis","volume":"106","author":"Quinones","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref143-bib143","doi-asserted-by":"crossref","first-page":"A867","DOI":"10.1136\/emermed-2017-207308.10","article-title":"Decision analysis modelling of diagnostic strategies for suspected pulmonary embolism in pregnancy: the DiPEP economic evaluation","volume":"34","author":"Pollard","year":"2017","journal-title":"Emerg Med J"},{"key":"key2024031312255700_ref144-bib144","first-page":"S232","article-title":"Cost-effectiveness of post-cesarean pharmacologic VTE prophylaxis in obese women","volume":"216","author":"Lee","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref145-bib145","doi-asserted-by":"crossref","first-page":"100311","DOI":"10.1016\/j.ajogmf.2021.100311","article-title":"Prophylactic anticoagulation for preterm premature rupture of membranes: a decision analysis","volume":"3","author":"Iroz","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"key2024031312255700_ref146-bib146","first-page":"S178","article-title":"Prospective cost analysis of low molecular weight heparin thromboprophylaxis post-planned caesarean section","volume":"186","author":"Houlihan","year":"2017","journal-title":"Ir J Med Sci"},{"key":"key2024031312255700_ref147-bib147","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2015.05.020","article-title":"Women\u2019s values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities","volume":"136","author":"Eckman","year":"2015","journal-title":"Thromb Res"},{"key":"key2024031312255700_ref148-bib148","doi-asserted-by":"crossref","first-page":"132S","DOI":"10.1097\/01.AOG.0000664672.29477.41","article-title":"Prophylactic anticoagulation while hospitalized for premature prelabor rupture of membranes: a decision analysis","volume":"135","author":"Dahl","year":"2020","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref149-bib149","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.AOG.0000227780.76353.05","article-title":"Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery","volume":"108","author":"Casele","year":"2006","journal-title":"Obstet Gynecol"},{"key":"key2024031312255700_ref150-bib150","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1016\/j.ajog.2016.11.379","article-title":"Optimal Strategy for Venous Thromboembolism Prophylaxis Following Cesarean Delivery: A Decision Analysis","volume":"216","author":"Bunce","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref151-bib151","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1160\/TH09-06-0349","article-title":"Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery: a decision analysis","volume":"103","author":"Blondon","year":"2010","journal-title":"Thromb Haemost"},{"key":"key2024031312255700_ref152-bib152","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1016\/j.ajog.2018.11.765","article-title":"742: Postpartum venous thromboembolism prophylaxis: a cost-effectiveness analysis","volume":"220","author":"Becker","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key2024031312255700_ref153-bib153","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/gim.2012.139","article-title":"A risk-benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomics","volume":"15","author":"Bajaj","year":"2013","journal-title":"Genet Med"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2044880","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/DFWT3873\/DFWT3873.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2044880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:09:16Z","timestamp":1710313756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/DFWT3873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":144,"alternative-id":["10.3310\/DFWT3873"],"URL":"https:\/\/doi.org\/10.3310\/dfwt3873","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"01-2021","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"04-2022","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"02-2023","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}